Hsinchu, Taiwan

Mei-Hui Chen

This inventor holds 2 USPTO granted patents. Top assignee: Genhealth Pharma Co., Ltd.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mei-Hui Chen. Retrieved from https://idiyas.com/inventor/mei-hui-chen-semwst46

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Mei-Hui Chen

Introduction

Mei-Hui Chen is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that promote nerve protection and myocardial regeneration. With a total of 2 patents, his work is paving the way for advancements in medical treatments.

Latest Patents

One of Mei-Hui Chen's latest patents is focused on nerve damage prevention and protection. This invention provides a novel compound that effectively prevents nerve damage and protects nerves, along with a preparation method and a pharmaceutical composition for its use. Another significant patent involves myocardial regeneration promoting compounds. This patent discloses a novel 3-aryl-2-propen-1-one series derivative and its synthesis processes, as well as its application as a pharmaceutical composition for promoting myocardial regeneration.

Career Highlights

Mei-Hui Chen is currently associated with Genhealth Pharma Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to improving health outcomes through scientific research and development.

Collaborations

Some of his notable coworkers include Lain-Tze Lee and Hui-Ping Tsai, who contribute to the collaborative efforts in their research and development projects.

Conclusion

Mei-Hui Chen's innovative work in the pharmaceutical field demonstrates his dedication to advancing medical science. His patents reflect a strong commitment to developing effective treatments for nerve damage and myocardial regeneration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…